ID   PRDX6_RAT               Reviewed;         224 AA.
AC   O35244;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 182.
DE   RecName: Full=Peroxiredoxin-6;
DE            EC=1.11.1.27 {ECO:0000269|PubMed:15004285};
DE   AltName: Full=1-Cys peroxiredoxin;
DE            Short=1-Cys PRX;
DE   AltName: Full=Acidic calcium-independent phospholipase A2;
DE            Short=aiPLA2;
DE            EC=3.1.1.4 {ECO:0000269|PubMed:17652308, ECO:0000269|PubMed:8999971};
DE   AltName: Full=Antioxidant protein 2;
DE   AltName: Full=Glutathione-dependent peroxiredoxin {ECO:0000305};
DE   AltName: Full=Lysophosphatidylcholine acyltransferase 5 {ECO:0000303|PubMed:26830860};
DE            Short=LPC acyltransferase 5;
DE            Short=LPCAT-5;
DE            Short=Lyso-PC acyltransferase 5;
DE            EC=2.3.1.23 {ECO:0000269|PubMed:26830860};
DE   AltName: Full=Non-selenium glutathione peroxidase;
DE            Short=NSGPx;
DE   AltName: Full=Thiol-specific antioxidant protein;
GN   Name=Prdx6; Synonyms=Aipla2, Aop2, Tsa;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RA   Kim T.-S., Feinstein S.I., Dodia C., Hennigan B.B., Fisher A.B.;
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Olfactory epithelium;
RA   Andreeva S.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PROTEIN SEQUENCE OF 2-41; 57-84; 98-118; 133-142; 156-162 AND 183-199, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [4]
RP   PROTEIN SEQUENCE OF 26-42 AND 146-163, FUNCTION, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8999971; DOI=10.1074/jbc.272.4.2542;
RA   Kim T.-S., Sundaresh C.S., Feinstein S.I., Dodia C., Skach W.R., Jain M.K.,
RA   Nagase T., Seki N., Ishikawa K., Nomura N., Fisher A.B.;
RT   "Identification of a human cDNA clone for lysosomal type Ca2+-independent
RT   phospholipase A2 and properties of the expressed protein.";
RL   J. Biol. Chem. 272:2542-2550(1997).
RN   [5]
RP   ERRATUM OF PUBMED:8999971.
RA   Kim T.-S., Sundaresh C.S., Feinstein S.I., Dodia C., Skach W.R., Jain M.K.,
RA   Nagase T., Seki N., Ishikawa K., Nomura N., Fisher A.B.;
RL   J. Biol. Chem. 272:10981-10981(1997).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ACTIVATION BY GLUTATHIONE.
RX   PubMed=15004285; DOI=10.1073/pnas.0400181101;
RA   Manevich Y., Feinstein S.I., Fisher A.B.;
RT   "Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires
RT   glutathionylation mediated by heterodimerization with pi GST.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:3780-3785(2004).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF HIS-26;
RP   SER-32 AND ASP-140.
RX   PubMed=17652308; DOI=10.1194/jlr.m700299-jlr200;
RA   Manevich Y., Reddy K.S., Shuvaeva T., Feinstein S.I., Fisher A.B.;
RT   "Structure and phospholipase function of peroxiredoxin 6: identification of
RT   the catalytic triad and its role in phospholipid substrate binding.";
RL   J. Lipid Res. 48:2306-2318(2007).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19700648; DOI=10.1152/ajplung.00052.2009;
RA   Sorokina E.M., Feinstein S.I., Milovanova T.N., Fisher A.B.;
RT   "Identification of the amino acid sequence that targets peroxiredoxin 6 to
RT   lysosome-like structures of lung epithelial cells.";
RL   Am. J. Physiol. 297:L871-L880(2009).
RN   [9]
RP   PHOSPHORYLATION AT THR-177 BY MAPK.
RX   PubMed=19140803; DOI=10.1042/bj20082061;
RA   Wu Y., Feinstein S.I., Manevich Y., Chowdhury I., Pak J.H., Kazi A.,
RA   Dodia C., Speicher D.W., Fisher A.B.;
RT   "Mitogen-activated protein kinase-mediated phosphorylation of peroxiredoxin
RT   6 regulates its phospholipase A(2) activity.";
RL   Biochem. J. 419:669-679(2009).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PHOSPHORYLATION.
RX   PubMed=26830860; DOI=10.1194/jlr.m064758;
RA   Fisher A.B., Dodia C., Sorokina E.M., Li H., Zhou S., Raabe T.,
RA   Feinstein S.I.;
RT   "A novel lysophosphatidylcholine acyl transferase activity is expressed by
RT   peroxiredoxin 6.";
RL   J. Lipid Res. 57:587-596(2016).
CC   -!- FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of
CC       hydrogen peroxide and organic hydroperoxides to water and alcohols,
CC       respectively (PubMed:15004285). Can reduce H(2)O(2) and short chain
CC       organic, fatty acid, and phospholipid hydroperoxides (By similarity).
CC       Also has phospholipase activity, can therefore either reduce the
CC       oxidized sn-2 fatty acyl group of phospholipids (peroxidase activity)
CC       or hydrolyze the sn-2 ester bond of phospholipids (phospholipase
CC       activity) (PubMed:15004285, PubMed:17652308, PubMed:8999971). These
CC       activities are dependent on binding to phospholipids at acidic pH and
CC       to oxidized phospholipds at cytosolic pH (By similarity). Plays a role
CC       in cell protection against oxidative stress by detoxifying peroxides
CC       and in phospholipid homeostasis (By similarity). Exhibits acyl-CoA-
CC       dependent lysophospholipid acyltransferase which mediates the
CC       conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-
CC       phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-
CC       3-phosphocholine or PC) (PubMed:26830860). Shows a clear preference for
CC       LPC as the lysophospholipid and for palmitoyl CoA as the fatty acyl
CC       substrate (By similarity). {ECO:0000250|UniProtKB:P30041,
CC       ECO:0000269|PubMed:15004285, ECO:0000269|PubMed:17652308,
CC       ECO:0000269|PubMed:26830860, ECO:0000269|PubMed:8999971}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a hydroperoxide + 2 glutathione = an alcohol + glutathione
CC         disulfide + H2O; Xref=Rhea:RHEA:62632, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:30879, ChEBI:CHEBI:35924, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:58297; EC=1.11.1.27;
CC         Evidence={ECO:0000269|PubMed:15004285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=3.1.1.4;
CC         Evidence={ECO:0000269|PubMed:17652308, ECO:0000269|PubMed:8999971};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + an acyl-CoA = a 1,2-
CC         diacyl-sn-glycero-3-phosphocholine + CoA; Xref=Rhea:RHEA:12937,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57643, ChEBI:CHEBI:58168,
CC         ChEBI:CHEBI:58342; EC=2.3.1.23;
CC         Evidence={ECO:0000269|PubMed:26830860};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + hexadecanoyl-CoA
CC         = 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + CoA;
CC         Xref=Rhea:RHEA:35983, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000250|UniProtKB:P30041};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35984;
CC         Evidence={ECO:0000250|UniProtKB:P30041};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexadecanoyl-sn-glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:41223, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72998, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000250|UniProtKB:P30041};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41224;
CC         Evidence={ECO:0000250|UniProtKB:P30041};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.25 mM for dipalmitoyl phosphatidylcholine
CC         {ECO:0000269|PubMed:8999971};
CC         Vmax=1.89 nmol/h/mg enzyme for dipalmitoyl phosphatidylcholine
CC         {ECO:0000269|PubMed:8999971};
CC       pH dependence:
CC         Optimum pH is 4 (for phospholipase activity).
CC         {ECO:0000269|PubMed:8999971};
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with GSTP1; mediates
CC       PRDX6 glutathionylation and regeneration (Probable). Interacts with
CC       APEX1. Interacts with STH. May interact with FAM168B (By similarity).
CC       May interact with HTR2A (By similarity). {ECO:0000250|UniProtKB:O08709,
CC       ECO:0000250|UniProtKB:P30041, ECO:0000305|PubMed:15004285}.
CC   -!- INTERACTION:
CC       O35244; P62259: Ywhae; Xeno; NbExp=2; IntAct=EBI-915490, EBI-356480;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19700648}. Lysosome
CC       {ECO:0000269|PubMed:19700648}. Note=Also found in lung secretory
CC       organelles (lamellar bodies). {ECO:0000269|PubMed:19700648}.
CC   -!- PTM: Phosphorylation at Thr-177 by MAP kinases increases the
CC       phospholipase activity of the enzyme (PubMed:19140803). Phosphorylated
CC       form exhibits a greater lysophosphatidylcholine acyltransferase
CC       activity compared to the non-phosphorylated form (PubMed:26830860).
CC       {ECO:0000269|PubMed:19140803, ECO:0000269|PubMed:26830860}.
CC   -!- PTM: Irreversibly inactivated by overoxidation of Cys-47 to sulfinic
CC       acid (Cys-SO(2)H) and sulfonic acid (Cys-SO(3)H) forms upon oxidative
CC       stress. {ECO:0000250|UniProtKB:P30041}.
CC   -!- MISCELLANEOUS: The active site is a conserved redox-active cysteine
CC       residue, the peroxidatic cysteine (C(P)), which makes the nucleophilic
CC       attack on the peroxide substrate. The peroxide oxidizes the C(P)-SH to
CC       cysteine sulfenic acid (C(P)-SOH), which then reacts with another
CC       cysteine residue, the resolving cysteine (C(R)), to form a disulfide
CC       bridge. The disulfide is subsequently reduced by an appropriate
CC       electron donor to complete the catalytic cycle. In this 1-Cys
CC       peroxiredoxin, no C(R) is present and C(P) instead forms a disulfide
CC       with a cysteine from another protein or with a small thiol molecule.
CC       C(P) is reactivated by glutathionylation mediated by glutathione S-
CC       transferase Pi, followed by spontaneous reduction of the enzyme with
CC       glutathione. {ECO:0000305|PubMed:15004285}.
CC   -!- SIMILARITY: Belongs to the peroxiredoxin family. Prx6 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF014009; AAB66341.1; -; mRNA.
DR   EMBL; Y17295; CAA76732.1; -; mRNA.
DR   RefSeq; NP_446028.1; NM_053576.2.
DR   AlphaFoldDB; O35244; -.
DR   SMR; O35244; -.
DR   BioGRID; 250165; 4.
DR   IntAct; O35244; 6.
DR   MINT; O35244; -.
DR   STRING; 10116.ENSRNOP00000030323; -.
DR   MoonProt; O35244; -.
DR   PeroxiBase; 4427; Rno1CysPrx.
DR   GlyGen; O35244; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O35244; -.
DR   PhosphoSitePlus; O35244; -.
DR   SwissPalm; O35244; -.
DR   jPOST; O35244; -.
DR   PaxDb; 10116-ENSRNOP00000030323; -.
DR   GeneID; 94167; -.
DR   KEGG; rno:94167; -.
DR   UCSC; RGD:71005; rat.
DR   AGR; RGD:71005; -.
DR   CTD; 9588; -.
DR   RGD; 71005; Prdx6.
DR   eggNOG; KOG0854; Eukaryota.
DR   HOGENOM; CLU_042529_4_1_1; -.
DR   InParanoid; O35244; -.
DR   OrthoDB; 103042at2759; -.
DR   PhylomeDB; O35244; -.
DR   TreeFam; TF105183; -.
DR   BRENDA; 1.11.1.27; 5301.
DR   BRENDA; 2.3.1.23; 5301.
DR   BRENDA; 3.1.1.4; 5301.
DR   Reactome; R-RNO-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:O35244; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000002896; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0047499; F:calcium-independent phospholipase A2 activity; ISO:RGD.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004601; F:peroxidase activity; ISO:RGD.
DR   GO; GO:0051920; F:peroxiredoxin activity; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0032060; P:bleb assembly; ISO:RGD.
DR   GO; GO:0045454; P:cell redox homeostasis; IBA:GO_Central.
DR   GO; GO:0098869; P:cellular oxidant detoxification; ISO:RGD.
DR   GO; GO:0046475; P:glycerophospholipid catabolic process; ISO:RGD.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IDA:RGD.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:RGD.
DR   GO; GO:0000302; P:response to reactive oxygen species; ISO:RGD.
DR   CDD; cd03016; PRX_1cys; 1.
DR   Gene3D; 3.40.30.10; Glutaredoxin; 1.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR024706; Peroxiredoxin_AhpC-typ.
DR   InterPro; IPR019479; Peroxiredoxin_C.
DR   InterPro; IPR045020; PRX_1cys.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR43503; MCG48959-RELATED; 1.
DR   PANTHER; PTHR43503:SF4; PEROXIREDOXIN-6; 1.
DR   Pfam; PF10417; 1-cysPrx_C; 1.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   PIRSF; PIRSF000239; AHPC; 1.
DR   SUPFAM; SSF52833; Thioredoxin-like; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Antioxidant; Cytoplasm; Direct protein sequencing; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Lysosome; Multifunctional enzyme;
KW   Oxidoreductase; Peroxidase; Phosphoprotein; Redox-active center;
KW   Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P30041"
FT   CHAIN           2..224
FT                   /note="Peroxiredoxin-6"
FT                   /id="PRO_0000135104"
FT   DOMAIN          5..169
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   REGION          31..40
FT                   /note="Required and sufficient for targeting to lysosomes
FT                   and lamellar bodies"
FT                   /evidence="ECO:0000269|PubMed:19700648"
FT   ACT_SITE        47
FT                   /note="Cysteine sulfenic acid (-SOH) intermediate; for
FT                   peroxidase activity"
FT                   /evidence="ECO:0000269|PubMed:17652308"
FT   ACT_SITE        140
FT                   /note="For phospholipase activity"
FT                   /evidence="ECO:0000305|PubMed:17652308"
FT   SITE            32
FT                   /note="Important for phospholipase activity"
FT                   /evidence="ECO:0000305|PubMed:17652308"
FT   MOD_RES         44
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P30041"
FT   MOD_RES         63
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P30041"
FT   MOD_RES         89
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P30041"
FT   MOD_RES         177
FT                   /note="Phosphothreonine; by MAPK"
FT                   /evidence="ECO:0000269|PubMed:19140803"
FT   MOD_RES         209
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P30041"
FT   MOD_RES         209
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08709"
FT   MUTAGEN         26
FT                   /note="H->A: Abolishes lipid binding."
FT                   /evidence="ECO:0000269|PubMed:17652308"
FT   MUTAGEN         32
FT                   /note="S->A: Abolishes lipid binding."
FT                   /evidence="ECO:0000269|PubMed:17652308"
FT   MUTAGEN         140
FT                   /note="D->A: Abolishes phospholipase activity, but does not
FT                   impair lipid binding."
FT                   /evidence="ECO:0000269|PubMed:17652308"
SQ   SEQUENCE   224 AA;  24819 MW;  EE41D9079A708FD9 CRC64;
     MPGGLLLGDE APNFEANTTI GHIRFHDFLG DSWGILFSHP RDFTPVCTTE LGRAAKLAPE
     FAKRNVKLIA LSIDSVEDHF AWSKDINAYN GAAPTEKLPF PIIDDKDRDL AILLGMLDPA
     EKDEKGMPVT ARVVFIFGPD KKLKLSILYP ATTGRNFDEI LRVVDSLQLT ASNPVATPVD
     WKKGESVMVL PTLPEEEAKQ LFPKGVFTKE LPSGKKYLRY TPQP
//
